Cat. No. |
Product Name |
Information |
PC-20672 |
MK-3402
Metallo-beta-lactamase inhibitor
|
MK-3402 is a small molecule metallo-beta-lactamase inhibitor with antibiotic activity. |
PC-20594 |
Compound 2B5
S. mutans VicR inhibitor
|
Compound 2B5 is a potent small molecule against S. mutans with IC50 of 1.9 uM, specifically targets the key response regulator VicR (Kd=87 uM) in both S. mutans and S. aureus. |
PC-20585 |
MAC13243
LolA inhibitor
|
MAC13243 is a small molecule inhibitor of the bacterial lipoprotein targeting chaperone LolA (Kd=7.5 uM), exhibits potent Gram-negative antibacterial activity with MIC value of 4 ug/mL (Pseudomonas aeruginosa PA01). |
PC-20571 |
IMP-1700
Bacterial AddAB complex inhibitor
|
IMP-1700 (IMP1700) is a potent, cell-active inhibitor of bacterial AddAB-mediated DNA repair, sensitizes MRSA to ciprofloxacin (CFX) with an EC50 of 5.9 nM. |
PC-20322 |
Regacin
RegA inhibitor
|
Regacin is a potent, specific inhibitor of bacterial AraC-like virulence regulator RegA with IC50 of 1.7 uM. |
PC-20319 |
Savirin
AgrA inhibitor
|
Savirin (S. aureus virulence inhibitor) is a small molecule inhibitor inhibiting agr quorum sensing in S. aureus by blocking the transcriptional function of AgrA. |
PC-20099 |
MMV1091186
P.f cIRS inhibitor
|
MMV1091186 (MMV 1091186) is an antimalarial compound that inhibit P. falciparum cytoplasmic isoleucyl tRNA synthetase (cIRS) with IC50 of 0.87 uM. |
PC-20097 |
GSK030
Antimalarial
|
GSK030 (GSK3212030A) is an antimalarial compound that targets blood-stage activity of the Plasmodium falciparum and Plasmodium vivax parasites. |
PC-20095 |
GSK147
Antimalarial
|
GSK147 (GSK-147) is an antimalarial compound that targets blood-stage activity of the Plasmodium falciparum and Plasmodium vivax parasites (Pf IC50=40 nM). |
PC-20094 |
GSK692
Antimalarial
|
GSK692 (GSK-692) is an antimalarial compound that targets blood-stage activity of the Plasmodium falciparum and Plasmodium vivax parasites (Pf IC50=10 nM). |
PC-20081 |
OTB-658
Antibiotic
|
OTB-658 (OTB658) is a novel oxazolidinone anti-tuberculosis agent, shows potent antibacterial activity against Mycobacterium tuberculosis, especially multi-drug resistant tuberculosis (MDR-TB) in vitro and in vivo. |
PC-20080 |
NTB-3119
Antibiotic
|
NTB-3119 (NTB3119) is a novel benzothiopyranone derivative and anti-tuberculosis agent with potent in vitro activity against both drug-susceptible and drug-resistant tuberculosis clinical strains. |